ZYME · ISSUER CIK 1937653
Zymeworks Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Zymeworks Inc. insiders reported $0.00 of open-market purchases and $358K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$358KInsider selling
−$358KNet open-market
Oct 9, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 202618:28 | Oct 9, 2026 | ZYME | EVP, Head of R&D | S · Sell | $25.85 | −13,832 | 23,205 | -37% | −$358K | ||
| Oct 9, 202618:28 | Oct 9, 2026 | ZYME | EVP, Head of R&D | M · Exercise | — | +37,037 | 37,037 | New | — |